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Activation of T  and B lymphocytes by binding of appropriate mitogens, antigens, 
or  other  ligands  leads  to  lymphokine  production  (1-4).  Wahl  and  co-workers  (5) 
reported that lymphokine production by complement receptor (CR)~-bearing guinea 
pig lymphocytes can be initiated  by binding of immune complexes. The same group 
mentioned  similar  activation  of human  CR-bearing  cells  (6).  They  attributed  the 
activity  to  B  lymphocytes.  In  our  research,  however,  immune  complex-induced 
lymphokine production  (ICLP) was exclusively a  property of non-B lymphocytes (7). 
Nylon wool nonadherent  lymphocytes containing < 1% membrane immunoglobulin- 
bearing  cells  produced  and  released  leukocyte  migration  inhibitory  factor  (LIF) 
activity  on  incubation  with  antibody-sensitized  erythrocytes  (EA)  or  aggregated 
human gamma globulin  (AgHGG). The capacity for ICLP was lost upon removal of 
lymphocytes adhering to EA monolayers, indicating that  Fc receptor  (FcR)-bearing 
cells  were  involved.  The  studies  reported  in  this  paper  were  designed  to  further 
characterize those cells and to determine whether their activation to LIF production 
is  a  result  of interaction  between  their  FcR  and  the  Fc portion  of IgG  (FcT).  The 
heterogeneity of the non-B FcR-bearing cells is well established  (8-11). Some, partic- 
ularly  the  killer  (K)  cells  responsible  for  antibody-dependent  cellular  cytotoxicity 
(ADCC)  (12), can be concentrated by removal of lymphocytes forming rosettes with 
sheep erythrocytes  (RBC)  (13,  14).  Initial observations using this technique revealed 
parallel  enrichment  of ICLP and ADCC.  This  led  to the study of Fcy-induced LIF 
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production after more critical separation of K  cells from natural killer (NK) and other 
FcR-bearing  cells  on  the  basis  of the  high-avidity  binding  of each  to  appropriate 
target cells (15). Using this separation technique, ICLP was found to be primarily or 
exclusively  a  function  of K  lymphocytes.  The  results  indicate  that  the  cytotoxic 
activity of K  cells is associated with cell activation and lymphokine production. They 
also  provide  further  evidence  that  the  K  cells  and  NK cells  among normal  resting 
lymphocytes are not identical populations, contrary to the views of others (16). 
For the study of the role of FeT and FcR in ICLP, we applied techniques previously 
used  (8,  17-20) to establish the importance of FcT binding to FoR in ADCC, and we 
followed the example of Berman and Weigel (21) in evaluating purified Fe  T fragments 
as potential activators. Induction of LIF production was found to require both intact 
FoR and an "active" FcT ligand. 
The possibility is discussed that K  cells have a significant noncytotoxic function in 
inflammatory  processes  by  virtue  of their  capacity  to  be  activated  to  lymphokine 
production by local or circulating immune complexes. 
Materials  and Methods 
Fractionation of Antisera.  Rabbit  antisera  to chicken and  sheep  RBC and  to P815  mouse 
mastoeytoma cells  as  well  as  normal  rabbit  serum  were  fractionated  on  Sephadex  G-200 
(Pharmacia Fine Chemicals, Piseataway, N. J.) columns to yield macroglobulin and IgG-rieh 
fractions (22). The latter were further fractionated by batch elution from DE52 DEAE-cellulose 
(Whatman  Inc., Clifton,  N. J.)  and  concentrated  (22).  No contaminating IgM or IgG was 
detected in the respective purified IgG or IgM fractions by immunoelectrophoresis or double 
immunodiffusion in gel using goat antisera specific for rabbit T or/~ chains (Dako Corp., Santa 
Barbara, Calif.). 
F(ab')2 fragments of IgG fractions of rabbit anti-chicken RBC and of normal rabbit serum 
were obtained by digestion with hog mucosa pepsin (Sigma Chemical Co., St. Louis, Mo.) and 
isolation on Sephadex G-100 (Pharmacia Fine Chemicals)  (22). The preparations were tested 
for intact IgG by passive hemagglutination using goat anti-rabbit Fc  T serum. No agglutination 
was observed. 
EA and Control RBC.  Chicken or sheep RBC were incubated with subagglutinating concen- 
trations of the corresponding rabbit antiserum or normal rabbit serum or with IgG, IgM, or 
IgG F(ab')2 fractions thereof. The resulting EA and control RBC were washed three times in 
Hanks' balanced salt  solution  (HBSS)  and suspended  in  RPMI  1640  (Gibco, Grand  Island 
Biological Co., Grand Island, N. Y.). 
Nucleated K  and NK  Target Cells.  P815  murine  mastoe~toma cells  grown in  RPMI  1640 
containing 10% fetal calf serum were sensitized with a  10-  dilution of IgG fraction of rabbit 
anti-P815  serum  for 30 min  at  37°C  for use as target cells  for K  cell  assays.  K562  human 
myeloid leukemia cells grown in the same manner were used as targets for NK cell assays (15). 
Soluble Fc  T Ligands.  Deaggregated human gamma globulin was taken as the upper one-third 
of uhracentrifuged (40,000 g for 2 h), pooled Cohn Fraction II. AgHGG was prepared from the 
deaggregated  preparation  by  heating  in  HBSS  (1  mg/ml)  at  63°C  for  30  min  (23).  FCT 
fragments were obtained by papain  (Sigma Chemical Co.) digestion of Cohn Fraction II and 
isolation on DEAE cellulose and Sephadex G-100 (22). Protein concentration was measured by 
the method of Lowry et al.  (24), and the concentration of contaminating IgG was estimated to 
be <0.03% of the total protein by radial immunodiffusion using goat anti-human ~ and ~ sera 
(Dako Corp.). 
Lymphoycte Suspensions.  Mononuclear cell  suspensions were prepared  by centrifugation on 
Ficoll-Hypaque  (specific  gravity,  1.077-1.080)  (24) of diluted,  heparinized  fresh  peripheral 
blood or defibrinated  leukocyte concentrates recovered as by-products in the preparation  of 
platelets for clinical use (American Red Cross Blood Services, Penn-Jersey Region, Philadelphia, 
Pa.). These cells (5 ×  107 to 10 X  107/ml)  were washed and incubated for 45 min at 37°C in a 
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supplemented with 10% heat-inactivated fetal calf serum. The nonadherent lymphocytes were 
eluted with an excess of the same HBSS. K cell-enriched lymphocytes (13, 14), were obtained 
by incubating  nonadherent lymphocytes with t00-fold excess of washed sheep RBC for 10 rain 
at 37°C, then centrifuging at 150 g for 5 min and leaving overnight at 4°C. The T cell-depleted 
fraction was removed from the interface. 
All lymphocyte suspensions were prepared aseptically, washed in HBSS, and resuspended in 
RPMI  1640. Total cell  recovery by these separation techniques was 65-95%,  with 93-99% 
viability of the cells recovered as measured by trypan blue exclusion. 
Enumeration of Lymphocytes.  B cells  were estimated by membrane immunofluorescence, T 
cells by rosette formation with untreated sheep RBC after overnight incubation at 4°C (26), 
and monocytes by cytoplasmic staining for nonspecific esterase  (27). FcR-bearing cells were 
counted as IgG EA-rosette-forming cells (7) and as conjugates with sensitized P815 cells in the 
single cell  agarose assay  (1 I), and K  and NK cells were enumerated in the same assay  by 
trypan blue staining of their conjugated target cells. Percentages of the various types of cells are 
reported as the means and standard deviations (SD) of the results of assays performed on 3-12 
lymphocyte preparations. 
Preferential Depletion and Concentration of K  and ArK Cells.  Nonadherent lymphocytes were 
mixed at a  i0:1 lymphocyte:target (L:T) ratio with K562 cells fixed in 0.025% glutaraldehyde 
or with similarly fixed P815 cells sensitized with rabbit anti-PSI5 serum, or with unsensitized 
control P815 cells at a 30:1 ratio (15). The cell mixtures were centrifuged at 40 g, resuspended, 
and  centrifuged  on  Ficoll-Hypaque.  The  cell  populations  depleted  of  NK  and  K  cells, 
respectively, were collected at the interface, washed in HBSS, and suspended in RPMI  1640. 
In some experiments, the pelleted cells enriched for NK or K cells attached to fixed K562 or 
sensitized P815 cells were saved for culture and generation of lymphokine supernates. 
K Activity.  ADCC was measured by a microtiter modification (11) of the SlCr-release assay 
(28) using as targets either 105 sensitized chicken EA or  104 P815  cells sensitized with rabbit 
anti-PSI5 IgG. Activity was expressed  as percent cytotoxicity at the stated L:T ratios. 
NK Activity.  These assays were performed in the same manner as in the ADCC assay except 
that 51Cr-labeled K562 cells were used as targets. 
ICLP.  Test and control supernatants were generated by incubating the indicated numbers 
of lymphocytes with stated concentrations of chicken or sheep EA, antibody-sensitized P815 
cells, AgHGG, or control preparations for  18 h  at  37°C. The control preparations were the 
corresponding  cells incubated with normal rabbit serum or, in the case ofAgHGG, deaggregated 
gammaglobulin (7). LIF activiy was assayed in these supernatants using a modification (7) of 
the  indirect  agarose-medium  assay  of Clausen  (29),  and  results  are  expressed  as  percent 
migration inhibition (MI): 
[  _(  testarea  ~] 
percent MI =  1  ~co-~tro'~rarea)J  ×  100, 
where  the  test  and control areas  were  calculated  from  the  means of four  to  six  replicate 
migration diameters. The standard errors of these pooled means were calculated using the ratio 
estimator (30). Because replicate values of percent MI were not normally distributed (7), the 
results of replicate experiments are reported as medians and ranges, and the Wilcoxan-Mann- 
Whitney ranking test  for unpaired measurements (30) was used for statistical comparisons. 
Protease-treated Lymphocytes.  Nonadherent lymphocytes (5 ×  107/ml) were incubated at 37°C 
with 15 mg (100 U)/ml of pronase from Streptomyces griseus (Sigma Chemical Co.) or 2.5 mg/ml 
of trypsin (Gibco, Grand Island Biological  Co.)  in HBSS. After 30 min, an equal volume of 
fetal calf serum was added and the cells washed three times in HBSS containing 10% fetal calf 
serum and suspended in RPMI 1640. The same concentrations of trypsin abolished the ability 
of nonadherent lymphocytes to form rosettes  with sheep RBC (32). 
Blocking Fcy with protein A.  EA,  AgHGG, and control preparations were  incubated with 
soluble staphylococcal protein A  (Pharmacia Fine Chemicals) at  indicated concentrations in 
HBSS for 30 min at 37°C. The EA and control RBC were washed three times in HBSS before 
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Results 
ICLP  by  K  Cell-enriched Lymphocytes.  Nonadherent  lymphocytes  were  enriched 
threefold to fourfold in K  cells as well as in other Fcy-binding cells by depletion of 
sheep RBC rosette-forming cells (Table I). Such T  cell-depleted lymphocyte prepa- 
rations had ADCC activity at approximately one-tenth of the L:T ratios required for 
similar levels of ~lCr-release using unfractionated nonadherent lymphocytes (Table 
II).  These K  cell-enriched lymphocytes were induced by chicken EA,  AgHGG, or 
sensitized P815 cells to produce significant LIF activity, also at approximately one- 
tenth of the concentration necessary for production of similar  levels of activity by 
unfractionated cells (Table III). 
Requirement for K  Cells but Not NK Cells.  When  K  cells were selectively removed 
from nonadherent  lymphocytes, <30%  of the EA-rosetting cells were removed, yet 
ADCC and ICLP were each depleted to essentially undetectable levels (Table IV). In 
contrast, selective depletion of NK cells had no effect on either ICLP or ADCC, but 
did remove NK activity. 
ICLP by K  but Not NK Cells.  High levels of LIF activity appeared in supernatants 
TAaLE  I 
Enrichment in FcR-bearing Cells and K Cells Associated with Removal of 
Sheep RBC Rosette-forming Cells  from Nonadherent Lymphocytes  * 
Nonadherent  K  cell-enriched 
lymphocytes8  lymphocytes§ 
EA-binding cells  15 +  3%  46 ±  11% 
Cells binding sensitized P815 cells  l0 ±  l%  33 ±  3% 
K  eells  3.5 ±  1%  11 ±  4% 
* Means ±  SD of results of three assays each. 
Contained <1% surface immunoglobulin-bearing cells, 69 ±  12% sheep RBC 
rosette-forming cells, and 0.2% esterase-positive monocytes. 
§ Contained 3 ±  2% surface immunoglobulin-bearing cells, 5 ±  2% sheep RBC 
rosette-forming cells, and < 1% esterase-positive monocytes. 
TABLE II 
Enrichment in K Celt Activity Associated with Removal of Sheep RBC 
Rosette-forming Cells  from Nonadherent Lymphocytes 
Percent 51Cr release ±  SD 
Target cells  L:T ratio  K  cell-  Nonadherent 
enriched 
lymphocytes  lymphocytes 
Chicken EA* 
Sensitized P815 cells§ 
20:1  51 +  6  ND:]: 
2:1  5+5  46-t-  ll 
40:1  55+  10  59±9 
20:1  43 ±  18  ND 
10:1  24 ±  9  59 ±  9 
5:1  12 ±  6  ND 
25:1  ND  41  ±  5 
0.6:1  ND  23 ±  6 
* Five experiments. 
:~ Not done. 
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TABLE III 
Fcy-induced Release of LIF Activity by K Cell-enriched vs.  Unfractionated 
Nonadherent Lymphocytes 
Fcy ligand/0.25 ml 
Number  Median percent MI (range) 
of lym- 
phocytes/  Nonadherent  K cell-enriched 
0.25 ml  lymphocytes  [ymphoeytes 
l0  T  chicken EA  106  1 (-21-19)*  35 (22-62)* 
107  38 (21-39)*  ND:~ 
60 ~g AgHGG  106  2  45 
107  38  ND 
25 #g AgHGG  106  -4  37 
107  27, 31  ND 
Sensitized P815 cells  10  n  ND  47 (43-53)§ 
107  23 (22-30)§  ND 
* Five experiments. 
:~ Not done. 
§ Three experiments. 
TABLE IV 
Preferential Removal of K  Cells but Not of NK Cells Decreases ICLP* 
Percent  Percent cytotoxicity  LIF activity 
Fraction of nonad-  Cells used for depletion  EA-roset-  L:T 20:1  as median 
herent lymphocytes  ting cells  percent MI 
:lz SD  ADCC:~  NK  (range)§ 
K cell-depleted  IgG-sensitized P815  9 :[: 2  .8 + 4  17 -e 8  2 (0-11) 
Control  P815 I[  13 :l: 3  32 +  10  19 ~  9  37 (35-42) 
NK cell-depleted  K562  12:1:3  42 +  7  2 :t: 4  38 (28-56) 
Control  P815  14 :lz 3  40 :lz 8  24 ± 9  36 (31-54) 
* Results of four experiments with K cell and 3 with NK cell depletion. 
IgG-sensitized P815 target  cells. 
§ Supernatants from  107 lymphocytes incubated overnight in 0.25 ml RPMI 1640 with 50 #g of AgHGG 
versus deaggregated  gamma globulin. 
[I Incubated with normal rabbit serum. 
from small numbers of isolated K  cells (2.5 ×  105/0.25 ml) when they were incubated 
overnight  with  the  antibody-sensitized  glutaraldehyde-treated  P815  cells  used  to 
isolate them (Table V). On the other hand, the NK cells conjugated to glutaraldehyde- 
treated  K562 cells yielded little or no LIF activity when incubated with  or without 
AgHGG. 
Requirement for FcR.  Nonadherent  lymphocytes  incubated with  pronase,  but  not 
those  incubated  with  trypsin,  lost  their  ability to  form  rosettes  with  EA  and  their 
ability to generate LIF on incubation for  18 h  with sheep  EA (Table VI). When  the 
pronase-treated, trypsin-treated, and untreated lymphocytes were incubated for 24 h, 
then cultured with sheep EA, no significant differences in the LIF activity of the three 
resulting supernatants were observed, with the pronase-treated cells having regained 
their FcR and their capacity for ICLP. 
Requirement  for  Fcy.  When  sheep  and  chicken  EA  prepared  with  IgG,  IgM,  or 
F(ab')2 fractions of rabbit antisera were cultured with nonadherent lymphocytes, only 
EA  sensitized  with  the  IgG  fraction  having  an  intact  Fc  region  stimulated  LIF NEVILLE  AND  LISCHNER  1873 
TABLE  V 
Isolated K  Cells but not NK Cells Mediate  ICLP* 
Number of  LIF activity of 
supernates as 
Conjugated  conjugates/  Added stimulant  median percent 
cells:~  0.25 ml 
MI (range) 
K cells  2.5 x  105  None  49 (47-57)§ 
NK cells  5 ×  105  AgHGG (25 ~tg)  0  (-5-11)  II 
* In  three  experiments  LIF  assays were  performed  on  supernatants  from 
overnight  cultures  of K  cells  conjugated  with  sensitized  glutaraldehyde- 
treated  P815  cells and  of NK  cells conjugated  to  glutaraldehyde-treated 
K562 ceils. 
:t: Cells removed in experiments reported in Table IV. 
§ PMN migration in the control supernatants was not significantly different 
from that in RPMI  1640 alone. Deaggregated human gamma globulin and 
fixed  P815  cells were  added  to  control  cultures.  Supernatants  from  these 
produced  no  inhibition  of migration  in  comparison  with  medium alone, 
indicating that neither fixed P815 cells nor conjugated K562 cells stimulated 
LIF production under these conditions. 
TABLE  VI 
Removal of Pronase-sensitive FcR Abolishes  EA-induced  LIF Activity * 
Hours of  Percent EA- 
Treatment  preincuba-  rosetting cells  Median percent MI 
of cells  tion~  +  SD  (range) 
None  0  18 +  5  44 (26-56)§ 
Pronase  0  4 +  3  3 (0-6)§ 
Trypsin  0  t6 +  3  40 (23-50) 
None  24  17 ±  3  35 (24-37) 
Pronase  24  19 :lz 6  21  (17-25) 
Trypsin  24  19 ±  3  30 (23-33) 
* In  three to six experiments LIF activity was measured in supernatants of 
enzyme-treated and  untreated nonadherent  lymphocytes (5  ×  106/0.1  ml) 
after incubation with equal numbers of sheep EA or control RBC. 
In  RPMI  1640  at  37°C  after  enzyme-treatment  and  before  supernatant 
production for LIF assay. 
§p=0.01. 
production (Table VII). In addition, when sheep EA and AgHGG were preincubated 
with staphylococcal Protein A,  there was marked inhibition of the ability of those 
active Fc'~ ligands to induce LIF production by nonadherent lymphocytes (Table 
VIII). 
Activation  of LIF  Production with  Fcy  Fragment.  Isolated  human  Fcy  fragments 
stimulated nonadherent lymphocytes to produce high levels of LIF activity (Fig.  1). 
The Fc? fragments did not inhibit leukocyte migration, and they blocked EA-rosette 
formation by the lymphocytes. 
Discussion 
Previous  discussions  of  the  function  of K  lymphocytes have  been  limited  to 
consideration of their apparent direct cytotoxicity for antibody-coated targets (12, 28, 
33). Thus, our demonstration here that at least some of the cells that mediate ADCC 
are those activated to release of lymphokine activity (LIF) when incubated with Fc), 1874  KILLER  CELLS  MEDIATE  LYMPHOKINE  PRODUCTION 
TABLE  VII 
Fc'~ Required to Stimulate Immune  Complex-induced LIF Production * 
Stimulant  Sensitizing Ig frac-  Median percent MI 
tion  (range) 
Sheep EA  IgG:l:  30 (18-45) 
Sheep EA  IgM§  6 (- 17-8) 
Chicken EA  IgG:]:  34 (28-44) 
Chicken EA  F(ab')2 II  -  1 (-5-2) 
* In four experiments nonadherent lymphocytes (5 ×  106/0.1  ml) were incu- 
bated  with  equal  numbers of stimulant or  control  cells and supernatants 
tested for LIF activity. 
Batch eluted from DEAE cellulose. 
§ Macroglobulin fraction from G-200 Sephadex. 
II The passive hemagglutinating titer of this fraction was 5 ×  10  -6 using a goat 
antiserum to rabbit lgG, and <1:8 using a goat antiserum to Fc fragment of 
rabbit y chain. 
TABLE  VIII 
Staphylococcal Protein A  Prevents EA and AgHGG from Stimulating ICLP* 
Protein A added  Median percent MI  Stimulant  per ml  (range) 
Sheep EA  0  25 (20-43)~: 
Sheep EA  10/Lg  8 (0-15):~ 
AgHGG  0  31  (29-32) 
AgHGG  50/tg  7 (4-15) 
* In three to  four experiments nonadherent lymphocytes (107/0.25  ml) were 
incubated with equal numbers of sheep EA or control RBC or with 250 p,g/ 
ml of AgHGG  or  deaggregated human gamma globulin  with  or  without 
preincubation  with  protein  A  and  the  LIF  activity  of the  supernatants 
assayed. 
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FIG.  l.  Stimulation of nonadherent lymphocytes to produce LIF-active supernatants by isolated 
Fc  7 fragments. In a single experiment, nonadherent lymphocytes (107/0.25 ml) were incubated with 
increasing concentrations of an Fc? fragment preparation and the supernatants tested in triplicate 
for LIF activity. The control supernatants were prepared by incubating the lymphocytes in RPMI 
1640,  then adding the appropriate  concentrations of Fc7  fragments  10  min  prior  to  harvesting. 
Each point represents the percent MI calculated from the mean test and control diameters for the 
triplicate assays. The bars indicate the standard errors of the pooled means. NEVILLE AND LISCHNER  1875 
ligands assumes special significance. Immune complex-induced release of LIF activity 
is probably associated with actual synthesis of this lymphokine because agents that 
block RNA and protein synthesis inhibit its production (7). If immune complexes can 
induce K cells to produce lymphokines in a manner quantitatively similar to antigen- 
induced lymphokine production by T  ceils, then they might have a  role in inflam- 
matory  processes  in  vivo  that  is  far  more  important  than  their  cytotoxicity for 
antibody-coated  cells.  Thus,  the  quantitative  aspects  of the  results  reported  here 
deserve further analysis. 
Previously it was shown (12, 34) by essentially complete depletion of activity on EA 
monolayers that, like K cells, the human lymphocytes responsible for ICLP bear FcR 
(7). In the first group of experiments reported here, lymphocyte populations enriched 
threefold to fourfold in K  cells and other FcR-bearing lymphocytes were found to 
exhibit markedly increased ICLP (Tables I and III). Both the Fc ligand-induced LIF 
production and the ADCC activity of those K cell-enriched lymphocytes were almost 
equal to or greater than those found with  10-fold more unfractionated nonadherent 
lymphocytes (Tables II and III). The quantitative significance of this parallel increase 
in activity remained in doubt, however, because of the limitations and variability of 
both the ADCC and LIF assays, particularly because the inactive cells in less purified 
preparations might be expected to interfere with cell contact in the ADCC assay, to 
absorb or inactivate LIF (7), or to exert suppressor or stimulatory influences on the 
ADCC  (35) or ICLP functions of the active cells.  Nevertheless, the apparent parallel 
concentration of ADCC  activity and ICLP suggested that  the effector cells of these 
two functions might belong to the same subpopulation of FcR-bearing ceils. Therefore, 
another depletion and enrichment procedure was used to analyze the subpopulation 
of FcR-bearing cells responsible for ICLP. 
The  preferential  depletion  of K  or  NK cells can  be  achieved  using  differences 
between the binding capacities of K  and NK cells for their respective target cells (15). 
Previously, those differences were used to demonstrate that K  cells and NK cells are 
separate subsets of FcR-bearing lymphocytes, which in turn are distinct from one or 
more additional subsets lacking both functions. In this investigation, we observed that 
the  removal  of the  subset  of FcR-bearing  lymphocytes that  mediates  ADCC  also 
removed cells active in  ICLP  (Table IV)  even though  >70%  of FcR-bearing cells 
remained  in  the  K  cell-depleted lymphocyte population.  In  contrast,  the  selective 
removal of NK cells did not affect LIF production. 
Positive selection experiments  indicated  that  K  cells  are  not  only necessary for 
ICLP but  that  they, or a  much smaller population of very closely associated ceils, 
actually secrete the lymphokine (Table V). When cultured with the sensitized targets 
to which they were conjugated, the isolated K cells yielded supernatants with greater 
activity than the activity produced by 40 times as many nonadherent lymphocytes. 
On  the other hand,  isolated  NK cells  produced  no measurable  LIF activity when 
cultured with AgHGG and  their conjugated target  cells.  In these experiments, the 
ICLP was clearly due to some or all of the K cells because the only difference between 
the  test  and  control  supernatants  was  the  presence  of  lymphocytes  coupled  to 
sensitized, fixed P815 ceils. Previously, it was shown that at the L:T ratios used for 
isolation >90% of such conjugates, which involve 2-4% of the nonadherent lympho- 
cytes, are cytotoxic for unfixed antibody-sensitized P815  cells  (15).  It  is,  of course, 
possible that the LIF activity was produced by only a small subfraction of those cells. 1876  KILLER CELLS MEDIATE LYMPHOKINE PRODUCTION 
The production ofsupernatants with maximum LIF activity by 106 isolated K cells 
per ml is comparable on a cell-to-cell basis with the production of supernatants with 
similar  LIF  activity  by  T  cells  stimulated  with  mitogens  (29,  36)  and  by  larger 
numbers  of lymphocytes from  highly  sensitized  persons  incubated  with  optimum 
concentrations of antigens (37,  38).  Thus, it appears that the amount of LIF activity 
released by K  cells on stimulation by Fcy ligands is of the same order of magnitude 
as that released by similar numbers of stimulated T  lymphocytes. Because the number 
of T  lymphocytes sensitized to a given antigen would rarely be expected to reach the 
2-4% of circulating lymphocytes that might respond to immune complexes, ICLP has 
the  potential  for  producing  inflammatory  effects  equal  to  or  greater  than  those 
presumably produced by antigen-stimulated T  cells. 
The  elimination  of ICLP  by  depletion  of K  cells  indicates  that  such  cells  are 
required but it does not address the question of whether the FcR are involved in cell 
activation for lymphokine production. This was investigated by testing for ICLP after 
enzymatic stripping of FoR from the lymphocytes (Table VI). It was shown that the 
removal of pronase-sensitive receptors but  not  of trypsin-sensitive surface  proteins 
from  lymphocytes  reduced  their  ability  to  form  rosettes  with  sheep  EA  and  to 
mediated ICLP. Both were regenerated by culturing the pronase-treated cells for 24 
h at 37°C. The same phenomenon has been noted in the case of ADCC (17). Although 
pronase  is  a  nondiscriminatory  protease  that  might  have  removed  other  surface 
membrane  molecules,  these  data  suggest  that  the  FcR  are  required  for  immune- 
complex-induced LIF activity. However, they do not indicate whether Fc binding is 
necessary. 
The involvement of Fcy in ICLP was confirmed by the observations that immune- 
complex-induced LIF production occurred only in the presence of particulate com- 
plexes with intact Fc region of IgG antibody (Table VII) and that preincubation of 
the complexes with the Fcy-binding agent, staphylococcal protein A, blocked much 
of the stimulating activity of those complexes (Table VIII). These data indicate that 
it is interaction of Fcy with FcR that activates K  cells to produce LIF activity, but 
they provide no evidence regarding the possible need for binding at other sites of the 
immunoglobulin molecule. 
Evidence that the binding of the FcR with Fc of IgG is sufficient for activation of 
lymphokine production without  involvement of other portions of the IgG molecule 
comes  from  the  experiments  with  isolated  Fcy  fragments.  The  latter  stimulated 
nonadherent  lymphocytes to produce LIF activity at  protein concentrations about 
eightfold lower than  the concentrations previously found to be required  for crude 
AgHGG preparations (7) (Fig.  1). It is possible, however, that enzymatic degradation 
of IgG with papain or further degradation by mononuclear phagocytes in culture (39) 
exposes new sites on the Fcy fragment with affinity for cell membrane receptors other 
than the FcR that recognize IgG immune complexes. 
As shown in the previous paper (7), deaggregated human gamma globulin, that is 
monomeric native IgG, does not induce lymphocytes to release measurable LIF. This 
is as expected because the avidity of the binding of monomeric IgG to the FcR of 
undefined lymphocytoid cells is much lower than  that of aggregated or complexed 
IgG, and aggregates and complexes are much more effective in blocking ADCC than 
is native IgG (19, 40). The exact associative or conformational changes that occur in 
the Fc portion of IgG molecules on binding to antigen or on intermolecular aggre- NEVILLE AND LISCFINER  1877 
gation that  make them bind more avidly to most cellular FcR and  to Clq are not 
known (41, 42), nor is it known whether the same changes occur with enzyme excision 
of Fcy fragments. Nevertheless, it is useful to consider all altered FcT ligands as active 
Fc to distinguish them from the Fc of native monomeric IgG, even though activation 
might  involve only  cross-linkage  of FcR  due  to  the  macromolecular structure  of 
complexes and aggregates. 
The ability of isolated  Fc  T fragments to stimulate  ICLP suggests  the  possibility 
that  cross-linkage of the FcR is not required for cell activation by active FcT. This 
speculation derives from the fact that  the FcT fragment does not readily aggregate 
even when heated (43)  and therefore might have been presented to the lymphocyte 
FcR in monomeric form in our experiments. This would not preclude, however, the 
possibility  that  monomeric Fcy might  aggregate  locally on  the  cell  membrane,  as 
occurs with other monomeric ligands and cells (44).  Such aggregation and resulting 
redistribution might trigger ICLP in the same manner as postulated for ADCC  (19). 
The  additional  possibility  that  Fc  T  fragments  activate  K  lymphocytes only  after 
predigestion by mononuclear phagocytes, as in the case of activation of mouse B cells 
(39), has not yet been investigated. 
In the experiment described in Table V, the stimulus to produce LIF was identical 
to the target cell in ADCC assays (except for glutaraldehyde fixation). In other words, 
it is likely that  whenever a  K  cell exerts its cytotoxic activity on a  target cell, it is 
simultaneously activated to release lymphokines. This is the first clear demonstration 
of cell activation in association with ADCC. It raises again the possibility that ADCC 
is itself the result of cytotoxic lymphokines produced by activated K  cells (45, 46). It 
appears,  however,  that  not  all  forms  of lymphocytotoxicity are  associated  with 
secretion of lymphokines because  isolated  NK cells did  not  release detectable  LIF 
activity when incubated with their conjugated target cells (c.f. last footnote to Table 
V). 
Until recently, it was widely held that the K and NK activities lay within the same 
population  (16).  Evidence has  been  accumulating,  however,  that  in  unstimulated 
normal lymphocyte populations cells with K cell activity can be almost quantitatively 
separated from those with NK activity (15, 47, 48). The data presented in this paper 
document  additional  distinct  functional  differences between  the  FoR-bearing cells 
that mediate ADCC and those mediating NK activity; K  cells are directly activated 
by immune complexes via their FcR, whereas NK cells are not activated to produce 
lymphokines by immune  complexes. The  functional differences between  cells that 
have  seemingly  similar  surface  membrane  receptors  might  be  related  to  different 
receptors or due  to differences in  density of similar  receptors per unit  area of cell 
membrane.  Possibly a  certain number of active FcT molecules must  be bound or a 
certain concentration attained to initiate cell activation. 
Because  the  direct  inhibitory effects of immune  complexes on  the  migration  of 
mononuclear phagocytes (36) makes assay of macrophage-active lymphokines in ICLP 
more difficult, our studies to date have been limited to the PMN-active lymphokines, 
LIF, and chemotactic factor. It is likely that other physiologically important lympho- 
kines are also produced in ICLP. As mentioned above, before these experiments, the 
primary function attributed to K  cells was cytolysis of antibody-coated targets, and 
this has been implicated in a  variety of processes in vivo (33, 49). The ability of K 1878  KILLER CELLS MEDIATE LYMPHOKINE PRODUCTION 
cells to produce soluble mediators in ICLP might be the bridge between  antibody- 
mediated effector mechanisms and cell-mediated inflammatory responses. 
Summary 
Cells that participate in immune complex-induced production of leukocyte migra- 
tion inhibitory factor (LIF) activity can be concentrated in a population making up 
2-4% of human peripheral blood lymphocytes in which >90% of the cells are active 
in a single cell antibody-dependent cellular cytotoxicity assay. When so concentrated, 
such killer (K) cell preparations are as efficient in producing LIF activity as mitogen- 
activated  T  lymphocytes. Other Fc receptor  (FcR)-bearing lymphocytes, including 
natural  killer  (NK)  cells,  do not  produce  measurable LIF activity when  incubated 
with  immune  complexes  (additional  evidence  that  the  K  and  NK  cells  among 
unstimulated  human  lymphocytes represent  distinct  populations).  Binding  of Fcy 
ligands  to  the  FoR  of  the  appropriate  lymphocytes,  possibly  without  need  for 
exogenous receptor bridging, is the only requirement  for their activation to immune 
complex-induced lymphokine production (ICLP). It is probable that ICLP by K cells 
plays a role in antibody-mediated effector functions in vivo. 
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